Stocks to watch
Stocks of interest at the close of trading on Friday, February 14.
NOX - NOXOPHARM - up 1.5 cents, or 6.7 per cent, to 24 cents
The Sydney biotech says a clinical trial suggests its radiation-sensitising suppository was able to extend the average lifespan of 32 men with terminal prostate cancer.
The men were treated with Veyonda in combination with Novartis' $6 billion experimental radioactive drug 177Lu-PSMA-617 at St Vincent's Hospital Sydney after at least two and in most cases three lines of therapy had failed.
They lived an average of 17.1 months despite two-thirds of them having over 20 tumours in their bones and lymph nodes.
BBN - BABY BUNTING - down 20 cents, or 5.3 per cent, to $3.60
The specialist baby goods retailer increased statutory profit by 0.6 per cent to $4.838 million in the six months to December 29, while revenue increased by 5.0 per cent to $186.39 million.
The board announced an interim fully franked dividend of 4.1 cents per share, up from 3.3 cents last year.
FAR - FAR LIMITED - down 0.3 cents, or 8.8 per cent, to 3.1 cents
WPL - WOODSIDE PETROLEUM - down 91 cents, or 2.7 per cent, to $32.83
The International Court of Arbitration of the International Chamber of Commerce has ruled in favour of Woodside and against FAR in relation to a long-running dispute over a stake in a $6 billion oil field in Senegal.
ConocoPhillips sold its stake in the Sangomar project to Woodside in 2016 for $US430 million; FAR, which also holds a stake in the project, argued it should have had a chance to pre-empt the sale.
Back to Breaking News
Print this page